Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H1N1 Vaccine in Lymphoid Malignancies
NCT01016548Phase 3Completed
- Sponsor
- University Health Network
- Start
- Nov 2009
- Primary completion
- Mar 2010
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines, Cancer Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) in influenza, sponsored by University Health Network. Started Nov 2009; status: completed.
02
Drugs
Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01016548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01016548.